Compounds > levodopa
Page last updated: 2024-08-17

levodopa and cholecystokinin

levodopa has been researched along with cholecystokinin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Ceballos, ML; Jenner, P; Marsden, CD; Rose, S; Taylor, MD1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, S1
Appollonio, I; Cocco, E; Ferrarese, C; Frattola, L; Panerai, AE; Piolti, R; Rovati, L1
Itoh, S; Katsuura, G1
Hirota, R; Itoh, S; Katsuura, G1
Asanuma, M; Iwata, E; Kondo, Y; Matsuura, K; Nishibayashi, S; Ogawa, N1

Trials

1 trial(s) available for levodopa and cholecystokinin

ArticleYear
Treatment of Parkinson's disease with proglumide, a CCK antagonist.
    Neurology, 1991, Volume: 41, Issue:5

    Topics: Aged; Cholecystokinin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Proglumide

1991

Other Studies

5 other study(ies) available for levodopa and cholecystokinin

ArticleYear
Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    European journal of pharmacology, 1992, Aug-25, Volume: 219, Issue:2

    Topics: Animals; Carbidopa; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neuropeptides; Neurotensin; Oxidopamine; Prosencephalon; Rats; Rats, Wistar; Substance P; Substantia Nigra

1992
Modulatory role for CCK-B antagonists in Parkinson's disease.
    Clinical neuropharmacology, 1990, Volume: 13, Issue:4

    Topics: Animals; Benzodiazepinones; Carbidopa; Cholecystokinin; Devazepide; Dopamine Agents; Levodopa; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenylurea Compounds; Receptors, Cholecystokinin; Saimiri

1990
Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
    European journal of pharmacology, 1981, Nov-05, Volume: 75, Issue:4

    Topics: Animals; Behavior, Animal; Cholecystokinin; Levodopa; Male; Motor Activity; Pargyline; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Thyrotropin-Releasing Hormone

1981
Effect of a cholecystokinin preparation on brain monoamines in the rat.
    The Japanese journal of physiology, 1980, Volume: 30, Issue:5

    Topics: Animals; Brain; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Levodopa; Male; Methyltyrosines; Norepinephrine; Pargyline; Rats; Serotonin

1980
Cholecystokinin alterations and effects of levodopa administration in the MPTP-treated mouse brain.
    Research communications in molecular pathology and pharmacology, 1995, Volume: 88, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Cholecystokinin; Dopamine; Levodopa; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuropeptides; Radioimmunoassay; Substance P; Thyrotropin-Releasing Hormone

1995